Cargando…

ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing

Detalles Bibliográficos
Autores principales:	Donnellan, Zoe, Bossi, Giovanna, Harper, Jane, Dukes, Joseph, Liddy, Nathaniel, Paston, Samantha, Mahon, Tara, Molloy, Peter, Sami, Malkit, Baston, Emma, Cameron, Brian, Johnson, Andrew, Vuidepot, Annelise, Hassan, Namir, Jakobsen, Bent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649398/ http://dx.doi.org/10.1186/2051-1426-3-S2-P299

Ejemplares similares

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8(+) and CD4(+) T cells
por: Boudousquie, Caroline, et al.
Publicado: (2017)

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
por: Harper, Jane, et al.
Publicado: (2018)

ImmTACs: Novel bi-specific agents for targeted cancer therapy
por: Oates, Joanne, et al.
Publicado: (2013)

Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy
por: Raman, Marine C C, et al.
Publicado: (2016)

Cancer-specific T cell receptor isolation for cancer immunotherapy
por: Baker, Debbie Emma, et al.
Publicado: (2015)

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors
por: Yang, Hongbing, et al.
Publicado: (2016)

Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
por: McCormack, Emmet, et al.
Publicado: (2012)

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells
por: Bossi, Giovanna, et al.
Publicado: (2013)

T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions
por: Cole, David K., et al.
Publicado: (2014)

TCR‐induced alteration of primary MHC peptide anchor residue
por: Madura, Florian, et al.
Publicado: (2019)

Tratado de entomología Imms
por: Richards, O. W.
Publicado: (1983)

Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
por: Freitas, Elisangela Oliveira, et al.
Publicado: (2015)

Tic-tac sans tac-tic
Publicado: (1999)

Re-measurement of $^{32}$Ar to test the IMME
por: Kreim, S
Publicado: (2012)

Increased Peptide Contacts Govern High Affinity Binding of a Modified TCR Whilst Maintaining a Native pMHC Docking Mode
por: Cole, David K., et al.
Publicado: (2013)

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer
por: van ‘t Land, Freek R., et al.
Publicado: (2022)

VaccImm: simulating peptide vaccination in cancer therapy
por: von Eichborn, Joachim, et al.
Publicado: (2013)

Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles
por: Ilyinskii, Petr O., et al.
Publicado: (2021)

NK cells specifically TCR-dressed to kill cancer cells
por: Mensali, Nadia, et al.
Publicado: (2019)

An unusual form of TAC–TAC sine autonomic phenomena
por: Pugach, Neil Lewis
Publicado: (2008)

ImmGen report: sexual dimorphism in the immune system transcriptome
por: Gal-Oz, Shani Talia, et al.
Publicado: (2019)

Adaptive Federated IMM Filter for AUV Integrated Navigation Systems
por: Lyu, Weiwei, et al.
Publicado: (2020)

An IMM-Aided ZUPT Methodology for an INS/DVL Integrated Navigation System
por: Yao, Yiqing, et al.
Publicado: (2017)

Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
por: Kishimoto, Takashi Kei
Publicado: (2020)

Effect of TaC Content on Microstructure and Properties of W-TaC Composites
por: Xu, Kai, et al.
Publicado: (2022)

Deep phenotypic characterization of NY-ESO TCR engineered T cells and tumor in patients with advanced myeloma
por: Davila, Eduardo, et al.
Publicado: (2015)

ImmTree: Database of evolutionary relationships of genes and proteins in the human immune system
por: Ortutay, Csaba, et al.
Publicado: (2007)

Breakdown of the Isobaric Multiplet Mass Equation (IMME) at A=33, T=3/2
por: Herfurth, F, et al.
Publicado: (2000)

ImmGen Report: Molecular definition of Natural Killer cell identity and activation
por: Bezman, Natalie A., et al.
Publicado: (2012)

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
por: Bilyard, Hilary, et al.
Publicado: (2014)

LinkedImm: a linked data graph database for integrating immunological data
por: Bukhari, Syed Ahmad Chan, et al.
Publicado: (2021)

ImmReg: the regulon atlas of immune-related pathways across cancer types
por: Jiang, Tiantongfei, et al.
Publicado: (2021)

Fundamentos de tac body/
por: Webb, W. Richard (Wayne Richard), 1945-
Publicado: (1999)

Transiente aplastische Krise (TAC)
Publicado: (2009)

Optimizing engineered TCR T cell therapy for synovial sarcoma
por: D'Angelo, Sandra, et al.
Publicado: (2015)

Organización administrativa y contable de un hospital de zona del IMMS.
por: Palacios López, Jose Luis
Publicado: (1987)

Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm
por: Woelke, Anna Lena, et al.
Publicado: (2011)

iMM1865: A New Reconstruction of Mouse Genome-Scale Metabolic Model
por: Khodaee, Saeideh, et al.
Publicado: (2020)

Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4(+) TCR-T Cells
por: Liang, Yanling, et al.
Publicado: (2022)

Improved Kidney Allograft Function after Early Conversion of Fast IR-Tac Metabolizers to LCP-Tac
por: Thölking, Gerold, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36ctc8bjrm6fns23gmr73bg9v0